Literature DB >> 12361243

Physiologic-pharmacologic interpretation of the constants in the Hill equation for neuromuscular block: a hypothesis.

Vladimir Nigrovic1, Anton Amann.   

Abstract

Neuromuscular block (NMB) is simulated in pharmacodynamic models using the concentration of a muscle relaxant (MR) in the effect compartment and two constants, gamma and IC50. No physiologic or pharmacologic interpretation is offered for either constant. We desired to explore whether the constants are properties of the muscle or the MR and to simulate NMB when the MR binds to two sites at a single receptor. Based on steady state conditions, we defined receptor occupancy using the equilibrium dissociation constants. Two concepts are introduced: threshold occupancy and occupancy at half-maximal NMB, Occ(NMB50). Threshold occupancy is defined as receptor occupancy at the motor end plate of a muscle fiber when the fiber fails to contract and Occ(NMB50) as the median threshold occupancy. NMB may be simulated as a function of either the concentration of the muscle relaxant or receptor occupancy. We suggest: (1) The distribution of threshold occupancies is an intrinsic property of a muscle and is characterized by two constants (gamma(o) and Occ(NMB50)); (2) gamma(o) is numerically equal to the slope of the NMB vs. concentration curves and is independent of the equilibrium dissociation constants. IC50 is code termined by Occ(NMB50) and by the equilibrium dissociation constants. (3) Binding of a muscle relaxant to the second binding site influences only the estimate of IC50 but not gamma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12361243     DOI: 10.1023/a:1019759725394

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  27 in total

1.  An alternate method for estimating the dose-response relationships of neuromuscular blocking drugs.

Authors:  A F Kopman; M M Klewicka; G G Neuman
Journal:  Anesth Analg       Date:  2000-05       Impact factor: 5.108

2.  Iontophoretic study of speed of action of various muscle relaxants.

Authors:  J C Min; I Bekavac; M I Glavinovic; F Donati; D R Bevan
Journal:  Anesthesiology       Date:  1992-08       Impact factor: 7.892

3.  Potentiation of neuromuscular blocking agents by calcium channel blockers in rats.

Authors:  G B Bikhazi; I Leung; C Flores; H M Mikati; F F Foldes
Journal:  Anesth Analg       Date:  1988-01       Impact factor: 5.108

4.  Ability of nondepolarizing neuromuscular blocking drugs to act as partial agonists at fetal and adult mouse muscle nicotinic receptors.

Authors:  G H Fletcher; J H Steinbach
Journal:  Mol Pharmacol       Date:  1996-05       Impact factor: 4.436

5.  Pharmacokinetics and pharmacodynamics of d-tubocurarine during nitrous oxide-narcotic and halothane anesthesia in man.

Authors:  D R Stanski; J Ham; R D Miller; L B Sheiner
Journal:  Anesthesiology       Date:  1979-09       Impact factor: 7.892

6.  Pharmacodynamic modeling of vecuronium-induced twitch depression. Rapid plasma-effect site equilibration explains faster onset at resistant laryngeal muscles than at the adductor pollicis.

Authors:  D M Fisher; J Szenohradszky; P M Wright; M Lau; R Brown; M Sharma
Journal:  Anesthesiology       Date:  1997-03       Impact factor: 7.892

7.  Pharmacokinetics and pharmacodynamics of atracurium in infants and children.

Authors:  D M Fisher; P C Canfell; M J Spellman; R D Miller
Journal:  Anesthesiology       Date:  1990-07       Impact factor: 7.892

8.  Pharmacokinetics, pharmacodynamics and dose-response relationships of atracurium administered i.v.

Authors:  B C Weatherley; S G Williams; E A Neill
Journal:  Br J Anaesth       Date:  1983       Impact factor: 9.166

9.  The effect of isoflurane and temperature on the actions of muscle relaxants in rat in vitro.

Authors:  L Aziz; Y Ohta; T Yamada; K Morita; M Hirakawa
Journal:  Anesth Analg       Date:  1995-06       Impact factor: 5.108

10.  d-Tubocurarine binding sites are located at alpha-gamma and alpha-delta subunit interfaces of the nicotinic acetylcholine receptor.

Authors:  S E Pedersen; J B Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.